News
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 16, 2025 it granted stock options to purchase an ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Mirdametinib is marketed under the brand name EZMEKLY ® in the European Union and is conditionally approved by the European Commission (EC) for the treatment of symptomatic, inoperable plexiform ...
The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.
Cardiologist explains that a heart attack isn't always fatal, and even patients with a very low survival chance can be saved with timely, advanced cardiac care.
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...
The White House says President Trump underwent a medical exam because of swelling in his legs and has been diagnosed with a ...
TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.
With the launch, Anumana became the first organization to utilize the marketplace. Philips now plans to make offer the ...
The AI model effectively spotted all subtypes of amyloidosis in the dataset, with an area under the receiver-operating characteristic curve (AUROC) of 0.93, a sensitivity of 85% for identifying ...
NewYork-Presbyterian researchers have developed a deep learning model that increases doctors' abilities to diagnose ...
Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results